Research Group Erik Norberg

Assistant Professor

Erik Norberg

Organizational unit: Norberg Erik group - Cellular metabolism
Department: Department of Physiology and Pharmacology (FYFA), C3


Tumor cells display metabolic profiles that are remarkably distinct from their tissue of origin to ensure fulfillment of their higher bioenergetic/biosynthetic needs required to support a rapid proliferation. The mechanisms underlying this metabolic reprogramming are divergent among tumors and are mainly regulated by oncogenes/tumor suppressors.

We are mainly focusing on the following overarching topics:

  • Metabolic Adaptations to Oncogenes and Tumor Suppressors.
  • Metabolic Signal Transduction.
  • Metabolism in Cancer vs. Normal cells.
  • Metabolic Control of Epigenetics.
  • Metabolic Control of Responsiveness to Clinically relevant Anti-cancer Regimens.

To study these questions we employ a translational approach starting from primary patient material paralleled by studies to elucidate the molecular mechanisms in cancer cells, normal cells and cancer mouse models, with the ultimate goal of identifying novel drug targets and prognostic markers. 

We are assessing the above mentioned aims by an integrative approach consisting of metabolomics, proteomics and transcriptomics as well as various genetic, biochemical and molecular biological tools. 

About Erik Norberg

  • M.Sc. Uppsala University, Uppsala, Sweden.
  • M.Sc. Stockholm Research School in Molecular Life Sciences, Karolinska Institutet, Stockholm, Sweden.
  • Ph.D. Karolinska Institutet.
  • PostDoc at Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.

Selected publications

Glucose metabolism provide distinct prosurvival benefits to non-small cell lung carcinomas.
Wu R, Galan-Acosta L, Norberg E
Biochem. Biophys. Res. Commun. 2015 May;460(3):572-7

Changing appetites: the adaptive advantages of fuel choice.
Stanley I, Ribeiro S, Giménez-Cassina A, Norberg E, Danial N
Trends Cell Biol. 2014 Feb;24(2):118-27

Metabolic signatures uncover distinct targets in molecular subsets of diffuse large B cell lymphoma.
Caro P, Kishan A, Norberg E, Stanley I, Chapuy B, Ficarro S, et al
Cancer Cell 2012 Oct;22(4):547-60
Co-first author: Caro P, Kishan A, Norberg E.

Critical role for hyperpolarization-activated cyclic nucleotide-gated channel 2 in the AIF-mediated apoptosis.
Norberg E, Karlsson M, Korenovska O, Szydlowski S, Silberberg G, Uhlén P, et al
EMBO J. 2010 Nov;29(22):3869-78


We are collaborating with colleagues at Harvard Medical School (Boston, MA, USA) and several groups at Karolinska Institute.

Open Positions

We are currently looking for highly motivated and talented Postdocs:

  •  2 financed PostDoc positions, start date Jan 2016.

Send your application and CV to: Erik Norberg